Trial Profile
Multicenter, double blind, randomized, placebo controlled trial of the efficacy and safety of usual care plus celecoxib compared to placebo for peri-operative and rehabilitation pain control and return to function in osteoarthritis patients undergoing total knee arthroplasty
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 04 Mar 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Musculoskeletal pain; Perioperative pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 05 Jan 2007 Status change
- 09 Nov 2006 New trial record.